Guo Feng

Statistics

Publications

Citations

351

H-Index

Active since

2016

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Ambrx (United States)

United States Military Academy

Torrey Pines Institute For Molecular Studies

Guo Feng is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacy, antibody conjugation, and targeted drug delivery.

ORCID

Publications per year

2016–2025

Publications

Discovery of Pyrophosphate Diesters as Tunable, Soluble, and Bioorthogonal Linkers for Site-Specific Antibody–Drug Conjugates

Jeffrey C. Kern, Mark T. Cancilla, Deborah Dooney et al. · Journal of the American Chemical Society · 2016 · 141 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Novel Phosphate Modified Cathepsin B Linkers: Improving Aqueous Solubility and Enhancing Payload Scope of ADCs

Jeffrey C. Kern, Deborah Dooney, Rena Zhang et al. · Bioconjugate Chemistry · 2016 · 94 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

Development of Anti-CD74 Antibody–Drug Conjugates to Target Glucocorticoids to Immune Cells

Philip E. Brandish, Anthony Palmieri, S. V. Antonenko et al. · Bioconjugate Chemistry · 2018 · 58 citations

Pharmacy, Immunology, Pharmacology +17

The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer

Ryan V. Quiroz, Michael H. Reutershan, Sebastian E. Schneider et al. · Journal of Medicinal Chemistry · 2021 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Global research trends and emerging hotspots in nano-drug delivery systems for lung cancer: a comprehensive bibliometric analysis (1998–2024)

Yu Cao, Y. Chen, Guo Feng et al. · Discover Oncology · 2025 · 13 citations · Full text

Pharmacy, Pharmacology, Drug Delivery +12

1–5 of 6